Straits Times Index
3,300.04 -3.15 (-0.10%) S&P 500
5,187.70 +6.96 (+0.13%) Dow
38,884.26 +31.99 (+0.08%) Nasdaq
16,332.56 -16.69 (-0.10%) Bitcoin USD
62,538.62 -1,064.24 (-1.67%) CMC Crypto 200
1,291.99 -73.13 (-5.35%)
AZN Jul 2024 95.000 put
| Previous close | 25.60 |
| Open | 25.60 |
| Bid | 17.55 |
| Ask | 20.35 |
| Strike | 95.00 |
| Expiry date | 2024-07-19 |
| Day's range | 25.60 - 25.60 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Reuters
UPDATE 2-AstraZeneca says it will withdraw COVID-19 vaccine globally as demand dips
AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic. The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe. "As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.
ReutersAstraZeneca says it will withdraw COVID-19 vaccine globally as demand dips
"As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied. The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development. London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.
